November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
COVID-19 Vaccination Safe in Patients with Previous Myocarditis, According to New Research
March 17th 2022Adults with previous acute myocarditis did not experience recurrence or serious adverse events after COVID-19 vaccination in a small study presented at ESC Acute CardioVascular Care Congress 2022.